CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 盐酸达拉他韦Daclatasvir Hydrochloride
Daclatasvir Hydrochloride

盐酸达拉他韦 杂质对照品Daclatasvir Hydrochloride Impurities

EP32 个杂质条目32 impurity entries

本页汇总 盐酸达拉他韦 的 32 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Daclatasvir Hydrochloride with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 盐酸达拉他韦(Daclatasvir Hydrochloride)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsTwo validated spectrofluorimeteric and high performance liquid chromatography (HPLC) methods with fluorescence detection for the analysis of a new anti-hepatitis C drug, daclatasvir hydrochloride, in raw material or tablet form and in biological fluids
    Luminescence : the journal of biological and chemical luminescence · 2018 · Aboshabana R et al.  ·  PMID 30350338  ·  DOI

盐酸达拉他韦 —— 原料药与杂质对照品Daclatasvir Hydrochloride — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Daclatasvir EP Impurity H structure
EPH
盐酸达拉他韦杂质52Daclatasvir EP Impurity H
Daclatasvir EP Impurity H
CAS No.1007882-27-0
Chemical FormulaC26H28N6
Purity>95%现货In stock
10mg25mg50mg100mg
Daclatasvir structure
—
达拉他韦Daclatasvir
Daclatasvir
CAS No.1009119-64-5
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir DiHydrochloride structure
—
双盐酸达拉他韦Daclatasvir DiHydrochloride
Daclatasvir DiHydrochloride
CAS No.1009119-65-6
Chemical FormulaC40H50N8O6·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 1 structure
1
盐酸达拉他韦杂质1Daclatasvir Hydrochloride Impurity 1
Daclatasvir Hydrochloride Impurity 1
CAS No.36934-45-9
Chemical FormulaC16H13BrO2
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 3 structure
3
盐酸达拉他韦杂质3Daclatasvir Hydrochloride Impurity 3
Daclatasvir Hydrochloride Impurity 3
CAS No.1007884-60-7
Chemical FormulaC33H39N7O3
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 4 structure
4
盐酸达拉他韦杂质4Daclatasvir Hydrochloride Impurity 4
Daclatasvir Hydrochloride Impurity 4
CAS No.2226541-13-3
Chemical FormulaC35H41N7O4
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 5 structure
5
盐酸达拉他韦杂质5Daclatasvir Hydrochloride Impurity 5
Daclatasvir Hydrochloride Impurity 5
CAS No.1256385-55-3
Chemical FormulaC29H32N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 6 structure
6
盐酸达拉他韦杂质6Daclatasvir Hydrochloride Impurity 6
Daclatasvir Hydrochloride Impurity 6
CAS No.28179-17-1
Chemical FormulaC16H10Br4O2
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 7 structure
7
盐酸达拉他韦杂质7Daclatasvir Hydrochloride Impurity 7
Daclatasvir Hydrochloride Impurity 7
CAS No.28179-18-2
Chemical FormulaC16H8Br6O2
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 10 structure
10
盐酸达拉他韦杂质10Daclatasvir Hydrochloride Impurity 10
Daclatasvir Hydrochloride Impurity 10
CAS No.2077207-88-4
Chemical FormulaC41H52N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 14 structure
14
盐酸达拉他韦杂质14Daclatasvir Hydrochloride Impurity 14
Daclatasvir Hydrochloride Impurity 14
CAS No.1009119-62-3
Chemical FormulaC26H28N6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 14 Tetrahydrochloride structure
14
盐酸达拉他韦杂质14 四盐酸盐Daclatasvir Hydrochloride Impurity 14 Tetrahydrochloride
Daclatasvir Hydrochloride Impurity 14 Tetrahydrochloride
CAS No.1447940-83-1
Chemical FormulaC26H28N6·4(HCl)
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 15 Monomer structure
15
盐酸达拉他韦杂质15 单体Daclatasvir Hydrochloride Impurity 15 Monomer
Daclatasvir Hydrochloride Impurity 15 Monomer
CAS No.1009117-28-5
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 15 Hydrochloride structure
15
盐酸达拉他韦杂质15 盐酸盐Daclatasvir Hydrochloride Impurity 15 Hydrochloride
Daclatasvir Hydrochloride Impurity 15 Hydrochloride
CAS No.2226822-77-9
Chemical FormulaC40H50N8O6·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 27 structure
27
盐酸达拉他韦杂质27Daclatasvir Hydrochloride Impurity 27
Daclatasvir Hydrochloride Impurity 27
CAS No.1417333-83-5
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 29 structure
29
盐酸达拉他韦杂质29Daclatasvir Hydrochloride Impurity 29
Daclatasvir Hydrochloride Impurity 29
CAS No.100146-16-5
Chemical FormulaC18H14N4
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 35 structure
35
盐酸达拉他韦杂质35Daclatasvir Hydrochloride Impurity 35
Daclatasvir Hydrochloride Impurity 35
CAS No.1009117-94-5
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 36 structure
36
盐酸达拉他韦杂质36Daclatasvir Hydrochloride Impurity 36
Daclatasvir Hydrochloride Impurity 36
CAS No.1009117-26-3
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 39 structure
39
盐酸达拉他韦杂质39Daclatasvir Hydrochloride Impurity 39
Daclatasvir Hydrochloride Impurity 39
CAS No.1009113-58-9
Chemical FormulaC42H54N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 40 structure
40
盐酸达拉他韦杂质40Daclatasvir Hydrochloride Impurity 40
Daclatasvir Hydrochloride Impurity 40
CAS No.1800502-75-3
Chemical FormulaC44H54N8O8
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 43 structure
43
盐酸达拉他韦杂质43Daclatasvir Hydrochloride Impurity 43
Daclatasvir Hydrochloride Impurity 43
CAS No.1085706-72-4
Chemical FormulaC40H49N7O7
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 48 structure
48
盐酸达拉他韦杂质48Daclatasvir Hydrochloride Impurity 48
Daclatasvir Hydrochloride Impurity 48
CAS No.1312335-98-0
Chemical FormulaC40H48Cl2N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 49 structure
49
盐酸达拉他韦杂质49Daclatasvir Hydrochloride Impurity 49
Daclatasvir Hydrochloride Impurity 49
CAS No.1312335-97-9
Chemical FormulaC40H49ClN8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 51 structure
51
盐酸达拉他韦杂质51Daclatasvir Hydrochloride Impurity 51
Daclatasvir Hydrochloride Impurity 51
CAS No.1009119-59-8
Chemical FormulaC26H28N6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 52 Tetrahydrochloride structure
52
盐酸达拉他韦杂质52 四盐酸盐Daclatasvir Hydrochloride Impurity 52 Tetrahydrochloride
Daclatasvir Hydrochloride Impurity 52 Tetrahydrochloride
CAS No.1009119-83-8
Chemical FormulaC26H28N6·4HCl
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 53 (Daclatasvir R,R,R,R isomer) structure
53
盐酸达拉他韦杂质53 (达拉他韦 R,R,R,R 异构体)Daclatasvir Hydrochloride Impurity 53 (Daclatasvir R,R,R,R isomer)
Daclatasvir Hydrochloride Impurity 53 (Daclatasvir R,R,R,R isomer)
CAS No.1417333-58-4
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 53 Dihydrochloride  (Daclatasvir R,R,R,R isomer Dihydrochloride) structure
53
盐酸达拉他韦杂质53 双盐酸盐 (达拉他韦 R,R,R,R 异构体双盐酸盐)Daclatasvir Hydrochloride Impurity 53 Dihydrochloride (Daclatasvir R,R,R,R isomer Dihydrochloride)
Daclatasvir Hydrochloride Impurity 53 Dihydrochloride (Daclatasvir R,R,R,R isomer Dihydrochloride)
CAS No.2698401-11-3
Chemical FormulaC40H50N8O6·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 54 structure
54
盐酸达拉他韦杂质54Daclatasvir Hydrochloride Impurity 54
Daclatasvir Hydrochloride Impurity 54
CAS No.1009119-18-9
Chemical FormulaC36H46N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 55 (Daclatasvir R,S,S,R isomer) structure
55
盐酸达拉他韦杂质55 (达拉他韦 R,S,S,R 异构体)Daclatasvir Hydrochloride Impurity 55 (Daclatasvir R,S,S,R isomer)
Daclatasvir Hydrochloride Impurity 55 (Daclatasvir R,S,S,R isomer)
CAS No.1009107-27-0
Chemical FormulaC40H50N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 56 structure
56
盐酸达拉他韦杂质56Daclatasvir Hydrochloride Impurity 56
Daclatasvir Hydrochloride Impurity 56
CAS No.1007882-23-6
Chemical FormulaC36H44N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 57 structure
57
盐酸达拉他韦杂质57Daclatasvir Hydrochloride Impurity 57
Daclatasvir Hydrochloride Impurity 57
CAS No.787-70-2
Chemical FormulaC14H10O4
Purity>95%询价On request
10mg25mg50mg100mg
Daclatasvir Hydrochloride Impurity 58 structure
58
盐酸达拉他韦杂质58Daclatasvir Hydrochloride Impurity 58
Daclatasvir Hydrochloride Impurity 58
CAS No.1240557-01-0
Chemical FormulaC14H11NO4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

盐酸达拉他韦 杂质谱研究要点Daclatasvir Hydrochloride — impurity profiling notes

下面这些是拿到 盐酸达拉他韦 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Daclatasvir Hydrochloride, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances